ArticleJournal of virus eradication2023

Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy.

M Schwarz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.